The Utilization of Cardiac Risk Ratio and Non-HDL Cholesterol Markers to Assess Cardiovascular Risk in Type 2 Diabetes Males with Lowered Serum DHT

    July 2022 in “ International Journal of Health Sciences ”
    Sanket Jheetay, Rinku Garg, Ritu Adhana, Jayballabh Kumar, Himani Muniyal, Anjali Verma, Jaspreet Jaura
    TLDR Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.
    The study investigated the relationship between cardiac risk markers and serum DHT levels in males with type 2 diabetes, focusing on the under-researched androgen, DHT. Conducted in India, the study involved 210 participants, split evenly between type 2 diabetes patients and controls. Researchers analyzed lipid parameters and serum DHT using conventional biochemical methods. The study aimed to explore the association of androgens with cardiovascular risk indicators, particularly in the context of male hypogonadism, which is linked to dyslipidemia, visceral obesity, and cardiovascular disorders.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results